Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
Authors:
- Barry J. MaronBMBarry J. Maron
- Paolo SpiritoPSPaolo Spirito
- Win-Kuang ShenWSWin-Kuang Shen
- Tammy S. HaasTHTammy S. Haas
- Francesco FormisanoFFFrancesco Formisano
- Mark S. LinkMLMark S. Link
- Andrew E. EpsteinAEAndrew E. Epstein
- Adrian K. AlmquistAAAdrian K. Almquist
- James P. DaubertJDJames P. Daubert
- Thorsten LawrenzTLThorsten Lawrenz
- Giuseppe BorianiGiuseppe Boriani
- N. A. Mark EstesNEN. A. Mark Estes
Top Cited Papers
Open Access
- 25 July 2007
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 298 (4) , 405-412
Abstract
The risk of sudden death in patients with hypertrophic cardiomyopathy (HCM) has been known for almost 50 years.1-6 Indeed, this disease is the most common cause of sudden cardiac death in young people,1-6 including trained athletes.7 However, only in the last few years has the implantable cardioverter-defibrillator (ICD) been systematically used as a potentially life-saving treatment in high-risk patients with HCM.8-10 Since HCM represents a less common indication for ICDs than coronary artery disease11-14 it is important to document its effectiveness in a large HCM population. In addition, although there is little residual controversy regarding the appropriateness of ICDs for secondary prevention, considerable uncertainty persists concerning patient selection for prophylactic ICD therapy in HCM. Therefore, to provide insights into these important clinical issues, we report here the findings in a large, international, multicenter cohort of patients with HCM who have received an ICD.Keywords
This publication has 24 references indexed in Scilit:
- Determinants of implantable defibrillator discharges in high-risk patients with hypertrophic cardiomyopathyHeart, 2007
- Cardioverter-defibrillator implantation in high-risk patients with hypertrophic cardiomyopathyHeart Rhythm, 2005
- Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart FailureNew England Journal of Medicine, 2005
- Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated CardiomyopathyNew England Journal of Medicine, 2004
- Long-term follow-up of implantable cardioverter defibrillator therapy for hypertrophic cardiomyopathyThe American Journal of Cardiology, 2004
- American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice GuidelinesEuropean Heart Journal, 2003
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002
- Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic CardiomyopathyNew England Journal of Medicine, 2000
- The Management of Hypertrophic CardiomyopathyNew England Journal of Medicine, 1997
- Idiopathic Hypertrophic Subaortic Stenosis: I. A Description of the Disease Based Upon an Analysis of 64 PatientsCirculation, 1964